Cargando…

Significance of ERβ expression in different molecular subtypes of breast cancer

PURPOSE: This study is to investigate the estrogen receptor β (ERβ) expression in molecular subtypes of breast cancer and clinic significance of ERβ expression. METHOD: The ERβ expression was detected in 730 cases of breast cancer tissue specimens by immunohistochemistry. Twenty-one patients were ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Liying, Meng, Jie, Yilamu, Dilimina, Jakulin, Adina, Fu, Minggang, Wang, Bowei, Abulajiang, Gulinaer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911955/ https://www.ncbi.nlm.nih.gov/pubmed/24457087 http://dx.doi.org/10.1186/1746-1596-9-20

Ejemplares similares

Expression of ERβ, ERα and Her-2 and distribution of molecular subtypes in Uygur and Han patients with breast cancer
por: GUO, LIYING, et al.
Publicado: (2014)

microRNA-10b expression and its correlation with molecular subtypes of early invasive ductal carcinoma
por: Guo, Chenming, et al.
Publicado: (2018)

Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
por: GUO, LIYING, et al.
Publicado: (2014)

ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups
por: Choi, Young, et al.
Publicado: (2022)

Gene polymorphisms in the PI3K/AKT/mTOR signaling pathway contribute to prostate cancer susceptibility in Chinese men
por: Liu, Ting, et al.
Publicado: (2017)

Expression of Foxp3 and interleukin-7 receptor and clinicopathological characteristics of patients with diffuse large B-cell lymphoma
por: Zhao, Yan, et al.
Publicado: (2020)

The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
por: Bertucci, François, et al.
Publicado: (2020)

Prognostic value of MYD88 L265P mutation in diffuse large B cell lymphoma via droplet digital PCR
por: Niu, Jing, et al.
Publicado: (2020)

RRM2 expression in different molecular subtypes of breast cancer and its prognostic significance
por: Abdel-Rahman, Manar Ahmed, et al.
Publicado: (2022)

Significant Association of Estrogen Receptor-β Isoforms and Coactivators in Breast Cancer Subtypes
por: Choi, Young, et al.
Publicado: (2023)

β2-microglobulin has a different regulatory molecular mechanism between ER(+) and ER(−) breast cancer with HER2(−)
por: Chai, Dandan, et al.
Publicado: (2019)

The subtype‐specific molecular function of SPDEF in breast cancer and insights into prognostic significance
por: Ye, Ting, et al.
Publicado: (2021)

ERβ in normal and malignant breast
por: Gustafsson, J-Å, et al.
Publicado: (2005)

Functional Significance of Selective Expression of ERα and ERβ in Mammary Gland Organ Culture
por: Mehta, Rajendra G.
Publicado: (2021)

Prognostic value of MTA1, SOX4 and EZH2 expression in esophageal squamous cell carcinoma
por: Liu, Wenying, et al.
Publicado: (2021)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype
por: Couture, Heather D., et al.
Publicado: (2018)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
por: Lundgren, Christine, et al.
Publicado: (2019)

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
por: Althobiti, Maryam, et al.
Publicado: (2020)

Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma
por: Ignatova, Ekaterina Olegovna, et al.
Publicado: (2022)

m(6)A levels and expression of its modification genes show significant differences in breast cancer molecular subtypes
por: Kleinbielen, Tamara, et al.
Publicado: (2022)

«Salivaomics» of Different Molecular Biological Subtypes of Breast Cancer
por: Bel’skaya, Lyudmila V., et al.
Publicado: (2022)

Clinical outcome of brain metastases differs significantly among breast cancer subtypes
por: Oehrlich, Nadja E., et al.
Publicado: (2017)

Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes
por: Heimes, Anne-Sophie, et al.
Publicado: (2020)

Interaction of Coumarin Phytoestrogens with ER(α) and ER(β): A Molecular Dynamics Simulation Study
por: Wang, Ting, et al.
Publicado: (2020)

Metaplastic breast cancer: Treatment and prognosis by molecular subtype
por: Hu, Jin, et al.
Publicado: (2021)

Expression of ERα, ERβ and Co-Regulator PELP1/MNAR in Colorectal Cancer: Prognostic Significance and Clinicopathologic Correlations
por: Grivas, Petros D., et al.
Publicado: (2009)

Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype
por: Chen, Xiao-Qiong, et al.
Publicado: (2020)

The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling
por: Faria, Michelle, et al.
Publicado: (2018)

A mouse model for Luminal epithelial like ER positive subtype of human breast cancer
por: Kumar, MJ Mahesh, et al.
Publicado: (2007)

FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
por: Levine, Kevin M., et al.
Publicado: (2019)

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
por: Wachter, David L., et al.
Publicado: (2014)

Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil
por: Carvalho, Filomena M, et al.
Publicado: (2014)

Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer
por: Fang, Hanyi, et al.
Publicado: (2021)

Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication
por: Hajirahimkhan, Atieh, et al.
Publicado: (2018)

Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy
por: Kim, Tae-Jung, et al.
Publicado: (2012)

Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics
por: Peng, Jing, et al.
Publicado: (2017)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers
por: Ballot, Elise, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vlgsm0rtn3im3siu6tfa3rpi94